Heregulin Co-opts PR Transcriptional Action Via Stat3 Role As a Coregulator to Drive Cancer Growth

Molecular Endocrinology
C J ProiettiP V Elizalde

Abstract

Accumulated findings have demonstrated the presence of bidirectional interactions between progesterone receptor (PR) and the ErbB family of receptor tyrosine kinases signaling pathways in breast cancer. We previously revealed signal transducer and activator of transcription 3 (Stat3) as a nodal convergence point between said signaling pathways proving that Stat3 is activated by one of the ErbBs' ligands, heregulin (HRG)β1 via ErbB2 and through the co-option of PR as a signaling molecule. Here, we found that HRGβ1 induced Stat3 recruitment to the promoters of the progestin-regulated cell cycle modulators Bcl-XL and p21(CIP1) and also stimulated Stat3 binding to the mouse mammary tumor virus promoter, which carries consensus progesterone response elements. Interestingly, HRGβ1-activated Stat3 displayed differential functions on PR activity depending on the promoter bound. Indeed, Stat3 was required for PR binding in bcl-X, p21(CIP1), and c-myc promoters while exerting a PR coactivator function on the mouse mammary tumor virus promoter. Stat3 also proved to be necessary for HRGβ1-induced in vivo tumor growth. Our results endow Stat3 a novel function as a coregulator of HRGβ1-activated PR to promote breast cancer growth. These find...Continue Reading

References

Jun 1, 1983·Molecular and Cellular Endocrinology·L H SunF R Frankel
Jun 15, 1997·The Journal of Clinical Investigation·Y FujioT Kishimoto
Jul 1, 1997·The Journal of Steroid Biochemistry and Molecular Biology·M R MooreR N Gentry
Jan 5, 1999·The Journal of Experimental Medicine·N KiuchiT Hirano
Nov 4, 2000·Biochemical and Biophysical Research Communications·M R MooreK M Franks
Jun 19, 2001·Proceedings of the National Academy of Sciences of the United States of America·T BowmanR Jove
Nov 20, 2002·The Journal of Biological Chemistry·Benjamin BarréOlivier Coqueret
May 12, 2004·Journal of Cellular Physiology·Enrico GalmozziSylvie Ménard
Jun 22, 2005·Journal of Molecular Neuroscience : MN·Ayelet Di SegniRonit Pinkas-Kramarski
Jan 7, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tanya GritskoRichard Jove
Mar 28, 2006·Experimental Gerontology·Susanne RohrbachJuergen Holtz
Jan 18, 2007·Molecular Endocrinology·Sayura Aoyagi, Trevor K Archer
May 12, 2009·Epigenetics : Official Journal of the DNA Methylation Society·Vicki E MacDonald, LeAnn J Howe
Aug 27, 2009·Proceedings of the National Academy of Sciences of the United States of America·Andrea R Daniel, Carol A Lange
Dec 15, 2010·Nature Genetics·Antoni HurtadoJason S Carroll
Jan 15, 2011·Genome Research·Aurélien A SérandourJérôme Eeckhoute
Jan 25, 2011·Nature Genetics·Sam JohnJohn A Stamatoyannopoulos
Aug 23, 2011·Expert Review of Endocrinology & Metabolism·Andrea R DanielCarol A Lange
Sep 3, 2011·Trends in Genetics : TIG·Luca MagnaniMathieu Lupien
Nov 8, 2011·Genes & Development·Kenneth S Zaret, Jason S Carroll

❮ Previous
Next ❯

Citations

Jul 7, 2016·Journal of Molecular Biology·Sandra L GrimmDean P Edwards
Dec 4, 2020·International Journal of Molecular Sciences·Alex HirtzHélène Dumond

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.